Novel insights into the role of caveolin-2 in cell- and tissue-specific signaling and function

Biochemistry Research International

Volumn , Issue , 2011, Pages

  Sowa, Grzegorz ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855596535     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2011/809259     Document Type: Review

References (55)

1. Williams T. M., Lisanti M. P., The caveolin genes: from cell biology to medicine Annals of Medicine 2004 36 8 584 595 (Pubitemid 40051435)
2. Das K., Lewis R. Y., Scherer P. E., Lisanti M. P., The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. Implications for tile assembly of caveolae membranes in vivo Journal of Biological Chemistry 1999 274 26 18721 18728
3. Sowa G., Pypaert M., Fulton D., Sessa W. C., The phosphorylation of caveolin-2 on serines 23 and 36 modulates caveolin-1-dependent caveolae formation Proceedings of the National Academy of Sciences of the United States of America 2003 100 11 6511 6516 (Pubitemid 36666612)
4. Mora R., Bonilha V. L., Marmorstein A., Scherer P. E., Brown D., Lisanti M. P., Rodriguez-Boulan E., Caveolin-2 localizes to the Golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1 Journal of Biological Chemistry 1999 274 36 25708 25717
5. Parolini I., Sargiacomo M., Galbiati F., Rizzo G., Engelman J. A., Okamoto T., Ikezu T., Scherer P. E., Mora R., Rodriguez-Boulan E., Peschle C., Lisanti M. P., Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the Golgi complex Journal of Biological Chemistry 1999 274 36 25718 25725
6. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., Menne J., Lindschau C., Mende F., Luft F. C., Schedl A., Hailer H., Kurzchalia T. V., Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice Science 2001 293 5539 2449 2452 (Pubitemid 32917325)
7. Razani B., Engelman J. A., Wang X. B., Schubert W., Zhang X. L., Marks C. B., Macalusol F., Russell R. G., Li M., Pestell R. G., Di Vizio D., Hou H., Kneitz B., Lagaud G., Christ G. J., Edelmann W., Lisanti M. P., Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities Journal of Biological Chemistry 2001 276 41 38121 38138
8. Krajewska W. M., Masowska I., Caveolins: structure and function in signal transduction Cellular and Molecular Biology Letters 2004 9 2 195 220 (Pubitemid 38902217)
9. Patel H. H., Murray F., Insel P. A., Caveolae as organizers of pharmacologically relevant signal transduction molecules Annual Review of Pharmacology and Toxicology 2008 48 359 391 (Pubitemid 351738158)
10. Patel H. H., Murray F., Insel P. A., G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains Handbook of Experimental Pharmacology 2008 186 167 184
11. Parat M. O., Chapter 4 the biology of caveolae. Achievements and perspectives International Review of Cell and Molecular Biology 2009 273 117 162
12. Razani B., Wang X. B., Engelman J. A., Battista M., Lagaud G., Zhang X. L., Kneitz B., Hou H., Christ G. J., Edelmann W., Lisanti M. P., Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae Molecular and Cellular Biology 2002 22 7 2329 2344 (Pubitemid 34224637)
13. Scheiffele P., Verkade P., Fra A. M., Virta H., Simons K., Ikonen E., Caveolin-1 and-2 in the exocytic pathway of MDCK cells Journal of Cell Biology 1998 140 4 795 806 (Pubitemid 28141218)
14. Lahtinen U., Honsho M., Parton R. G., Simons K., Verkade P., Involvement of caveolin-2 in caveolar biogenesis in MDCK cells FEBS Letters 2003 538 13 85 88 (Pubitemid 36287430)
15. Fujimoto T., Kogo H., Nomura R., Une T., Isoforms of caveolin-1 and caveolar structure Journal of Cell Science 2000 113, part 19 3509 3517
16. Sowa G., Xie L., Xu L., Sessa W. C., Serine 23 and 36 phosphorylation of caveolin-2 is differentially regulated by targeting to lipid raft/caveolae and in mitotic endothelial cells Biochemistry 2008 47 1 101 111
17. Lee H., Park D. S., Wang X. B., Scherer P. E., Schwartz P. E., Lisanti M. P., Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1 Journal of Biological Chemistry 2002 277 37 34556 34567
18. Xiao B. W., Lee H., Capozza F., Marmon S., Sotgia F., Brooks J. W., Campos-Gonzalez R., Lisanti M. P., Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27) Biochemistry 2004 43 43 13694 13706 (Pubitemid 39431053)
19. Xie L., Frank P. G., Lisanti M. P., Sowa G., Endothelial cells isolated from caveolin-2 knockout mice display higher proliferation rate and cell cycle progression relative to their wild-type counterparts American Journal of PhysiologyCell Physiology 2010 298 3 C693 C701
20. Shatseva T., Lee D. Y., Deng Z., Yang B. B., MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2 Journal of Cell Science 2011 124 16 2826 2836
21. Xie L., Vo-Ransdell C., Abel B., Willoughby C., Jang S., Sowa G., Caveolin-2 is a negative regulator of anti-proliferative function and signaling of transforming growth factor beta in endothelial cells American Journal of PhysiologyCell Physiology 2011 301 5 C1161 C1174
22. Razani B., Woodman S. E., Lisanti M. P., Caveolae: from cell biology to animal physiology Pharmacological Reviews 2002 54 3 431 467
23. Kim S., Pak Y., Caveolin-2 regulation of the cell cycle in response to insulin in Hirc-B fibroblast cells Biochemical and Biophysical Research Communications 2005 330 1 88 96 (Pubitemid 40394939)
24. Kwon H., Jeong K., Pak Y., Identification of pY19-caveolin-2 as a positive regulator of insulin-stimulated actin cytoskeleton-dependent mitogenesis Journal of Cellular and Molecular Medicine 2009 13 8 1549 1564
25. Kwon H., Jeong K., Hwang E. M., Park J. Y., Pak Y., A novel domain of caveolin-2 that controls nuclear targeting: regulation of insulin-specific ERK activation and nuclear translocation by caveolin-2 Journal of Cellular and Molecular Medicine 2011 15 4 888 908
26. Engelman J. A., Zhang X. L., Lisanti M. P., Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers FEBS Letters 1998 436 3 403 410 (Pubitemid 28482971)
27. Engelman J. A., Lee R. J., Karnezis A., Bearss D. J., Webster M., Siegel P., Muller W. J., Windle J. J., Pestell R. G., Lisanti M. P., Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo: implications for human breast cancer Journal of Biological Chemistry 1998 273 32 20448 20455 (Pubitemid 28377612)
28. Scherer P. E., Lewis R. Y., Volonté D., Engelman J. A., Galbiati F., Couet J., Kohtz D. S., Van Donselaar E., Peters P., Lisanti M. P., Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo Journal of Biological Chemistry 1997 272 46 29337 29346 (Pubitemid 27498228)
29. Hu Y. C., Lam K. Y., Law S., Wong J., Srivastava G., Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESVV) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC Clinical Cancer Research 2001 7 11 3519 3525 (Pubitemid 33069989)
30. Fong A., Garcia E., Gwynn L., Lisanti M. P., Fazzari M. J., Li M., Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation American Journal of Clinical Pathology 2003 120 1 93 100 (Pubitemid 37046375)
31. Wikman H., Seppnen J. K., Sarhadi V. K., Kettunen E., Salmenkivi K., Kuosma E., Vainio-Siukola K., Nagy B., Karjalainen A., Sioris T., Salo J., Hollmén J., Knuutila S., Anttila S., Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays Journal of Pathology 2004 203 1 584 593 (Pubitemid 38529039)
32. Elsheikh S. E., Green A. R., Rakha E. A., Samaka R. M., Ammar A. A., Powe D., Reis-Filho J. S., Ellis I. O., Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype British Journal of Cancer 2008 99 2 327 334
33. Savage K., Leung S., Todd S. K., Brown L. A., Jones R. L., Robertson D., James M., Parry S., Pinilla S. M. R., Huntsman D., Reis-Filho J. S., Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis Breast Cancer Research and Treatment 2008 110 2 245 256 (Pubitemid 351793874)
34. Gould M. L., Williams G., Nicholson H. D., Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression Prostate 2010 70 15 1609 1621
35. Lee S., Kwon H., Jeong K., Pak Y., Regulation of cancer cell proliferation by caveolin-2 down-regulation and re-expression International Journal of Oncology 2011 38 5 1395 1402
36. Zaas D. W., Duncan M. J., Li G., Wright J. R., Abraham S. N., Pseudomonas invasion of type I pneumocytes is dependent on the expression and phosphorylation of caveolin-2 Journal of Biological Chemistry 2005 280 6 4864 4872 (Pubitemid 40288660)
37. Zaas D. W., Swan Z. D., Brown B. J., Li G., Randell S. H., Degan S., Sunday M. E., Wright J. R., Abraham S. N., Counteracting signaling activities in lipid rafts associated with the invasion of lung epithelial cells by Pseudomonas aeruginosa Journal of Biological Chemistry 2009 284 15 9955 9964
38. Chan Y. G. Y., Cardwell M. M., Hermanas T. M., Uchiyama T., Martinez J. J., Rickettsial outer-membrane protein B (rOmpB) mediates bacterial invasion through Ku70 in an actin, c-Cbl, clathrin and caveolin 2-dependent manner Cellular Microbiology 2009 11 4 629 644
39. Webley W. C., Norkin L. C., Stuart E. S., Caveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1 BMC Infectious Diseases 2004 4 23
40. Fujimoto T., Parton R. G., Not just fat: the structure and function of the lipid droplet Cold Spring Harbor Perspectives in Biology 2011 3 3
41. Fujimoto T., Kogo H., Ishiguro K., Tauchi K., Nomura R., Caveolin-2 is targeted to lipid droplets, a new membrane domain in the cell Journal of Cell Biology 2001 152 5 1079 1085 (Pubitemid 34286082)
42. Ostermeyer A. G., Paci J. M., Zeng Y., Lublin D. M., Munro S., Brown D. A., Accumulation of caveolin in the endoplasmic reticulum redirects the protein to lipid storage droplets Journal of Cell Biology 2001 152 5 1071 1078 (Pubitemid 34286081)
43. Gmez-Ruiz A., de Miguel C., Campin J., Martnez J. A., Milagro F. I., Time-dependent regulation of muscle caveolin activation and insulin signalling in response to high-fat diet FEBS Letters 2009 583 19 3259 3264
44. Moreno M., Molina H., Amigo L., Zanlungo S., Arrese M., Rigotti A., Miquel J. F., Hepatic overexpression of caveolins increases bile salt secretion in mice Hepatology 2003 38 6 1477 1488 (Pubitemid 37466974)
45. Scherer P. E., Okamoto T., Chun M., Nishimoto I., Lodish H. F., Lisanti M. P., Identification, sequence, and expression of caveolin-2 defines a caveolin gene family Proceedings of the National Academy of Sciences of the United States of America 1996 93 1 131 135 (Pubitemid 26041482)
46. Rybin V. O., Grabham P. W., Elouardighi H., Steinberg S. F., Caveolae-associated proteins in cardiomyocytes: caveolin-2 expression and interactions with caveolin-3 American Journal of PhysiologyHeart and Circulatory Physiology 2003 285 1 H325 H332
47. Capozza F., Cohen A. W., Cheung M. W. C., Sotgia F., Schubert W., Battista M., Lee H., Frank P. G., Lisanti M. P., Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells American Journal of PhysiologyCell Physiology 2005 288 3 C677 C691
48. Shmuel M., Nodel-Berner E., Hyman T., Rouvinski A., Altschuler Y., Caveolin 2 regulates endocytosis and trafficking of the M1 muscarinic receptor in MDCK epithelial cells Molecular Biology of the Cell 2007 18 5 1570 1585 (Pubitemid 46717541)
49. Parker S., Walker D. S., Ly S., Baylis H. A., Caveolin-2 is required for apical lipid trafficking and suppresses basolateral recycling defects in the intestine of caenorhabditis elegans Molecular Biology of the Cell 2009 20 6 1763 1771
50. Langlois S., Cowan K. N., Shao Q., Cowan B. J., Laird D. W., Caveolin-1 and -2 interact with connexin43 and regulate gap junctional intercellular communication in keratinocytes Molecular Biology of the Cell 2008 19 3 912 928 (Pubitemid 351481808)
51. Jasmin J. F., Mercier I., Hnasko R., Cheung M. W. C., Tanowitz H. B., Dupuis J., Lisanti M. P., Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression Cardiovascular Research 2004 63 4 747 755 (Pubitemid 39078689)
52. Woodman S. E., Ashton A. W., Schubert W., Lee H., Williams T. M., Medina F. A., Wyckoff J. B., Combs T. P., Lisanti M. P., Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli American Journal of Pathology 2003 162 6 2059 2068 (Pubitemid 36613061)
53. Schubert W., Sotgia F., Cohen A. W., Capozza F., Bonuccelli G., Bruno C., Minetti C., Bonilla E., DiMauro S., Lisanti M. P., Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation American Journal of Pathology 2007 170 1 316 333 (Pubitemid 47339210)
54. Jasmin J. F., Yang M., Iacovitti L., Lisanti M. P., Genetic ablation of caveolin-1 increases neural stem cell proliferation in the subventricular zone (SVZ) of the adult mouse brain Cell Cycle 2009 8 23 3978 3983
55. de Almeida C. J., Witkiewicz A. K., Jasmin J. F., Tanowitz H. B., Sotgia F., Frank P. G., Lisanti M. P., Caveolin-2-deficient mice show increased sensitivity to endotoxemia Cell Cycle 2011 10 13 2151 2161